UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1943-01-01

Employees: 8.1K

Market Cap: -

Website: http://www.utsouthwestern.edu

Clinical Trials

Multimodal Monitoring of Cerebral Autoregulation After Pediatric Brain Injury

Not Applicable

Recruiting

Conditions: Traumatic Brain Injury
Brain Injuries
Brain Injury, Vascular

Interventions: Device: Transcranial Doppler

First Posted Date: 2020-01-27

Last Posted Date: 2024-02-28

Lead Sponsor: University of Texas Southwestern Medical Center

Target Recruit Count: 30

Registration Number: NCT04242602

Locations: 🇺🇸
Children's Medical Center, Dallas, Texas, United States

Non-Invasive Testing to Evaluate Wound Healing in Diabetes

Recruiting

Conditions: Diabetic Foot Ulcer

Interventions: Device: SnapshotNIR, Kent Imaging

First Posted Date: 2020-01-18

Last Posted Date: 2024-08-09

Lead Sponsor: University of Texas Southwestern Medical Center

Target Recruit Count: 700

Registration Number: NCT04232631

Locations: 🇺🇸
UT Southwestern Medical Center at Dallas, Dallas, Texas, United States

Characterization of AmnioExcel Plus in Two Treatment Paradigms

Not Applicable

Completed

Conditions: Diabetic Foot Ulcer

Interventions: Device: Amnio Excel + weekly
Device: Amnio Excel + max every 2 weeks

First Posted Date: 2020-01-18

Last Posted Date: 2023-07-24

Lead Sponsor: University of Texas Southwestern Medical Center

Target Recruit Count: 40

Registration Number: NCT04233580

Locations: 🇺🇸
UT Southwestern Medical Center at Dallas, Dallas, Texas, United States

Cladribine Tablets After Treatment With Natalizumab (CLADRINA)

Phase 4

Active, not recruiting

Conditions: Multiple Sclerosis

Interventions: Drug: Cladribine

First Posted Date: 2019-11-26

Last Posted Date: 2024-12-02

Lead Sponsor: University of Texas Southwestern Medical Center

Target Recruit Count: 40

Registration Number: NCT04178005

Locations: 🇺🇸
UT Southwestern Medical center, Dallas, Texas, United States
🇺🇸
College Park Family Care Center Physicians Group, Overland Park, Kansas, United States

Erlotinib for Hepatocellular Carcinoma Chemoprevention

Phase 2

Not yet recruiting

Conditions: Cirrhosis, Liver

Interventions: Drug: Erlotinib Hydrochloride

First Posted Date: 2019-11-21

Last Posted Date: 2024-08-12

Lead Sponsor: University of Texas Southwestern Medical Center

Target Recruit Count: 30

Registration Number: NCT04172779

Hyperinflation Respiratory Therapies in Cardiac Surgery Patients

Not Applicable

Recruiting

Conditions: Pulmonary Disease
Postoperative Complications

Interventions: Device: Metaneb
Device: EzPAP
Device: Intermittent Positive Pressure Breathing (IPPB)

First Posted Date: 2019-11-15

Last Posted Date: 2024-10-31

Lead Sponsor: University of Texas Southwestern Medical Center

Target Recruit Count: 324

Registration Number: NCT04164173

Locations: 🇺🇸
UT Southwestern Clements University Hospital, Dallas, Texas, United States

Extreme Lipids Repository

Recruiting

Conditions: Lipoprotein Disorder

Interventions: Other: No intervention is involved in this study

First Posted Date: 2019-11-08

Last Posted Date: 2024-04-16

Lead Sponsor: University of Texas Southwestern Medical Center

Target Recruit Count: 250

Registration Number: NCT04156997

Locations: 🇺🇸
University of Texas Southwestern Medical Center - Ambulatory Clinic, Dallas, Texas, United States
🇺🇸
Parkland Health Hospital System, Dallas, Texas, United States

Dystonia Coalition Projects

Terminated

Conditions: Dystonia

First Posted Date: 2019-11-07

Last Posted Date: 2019-11-07

Lead Sponsor: University of Texas Southwestern Medical Center

Target Recruit Count: 2

Registration Number: NCT04156022

Ice Application for Postoperative Pain

Not Applicable

Completed

Conditions: Postoperative Pain

Interventions: Other: Ice

First Posted Date: 2019-10-31

Last Posted Date: 2024-10-29

Lead Sponsor: University of Texas Southwestern Medical Center

Target Recruit Count: 74

Registration Number: NCT04145791

Locations: 🇺🇸
Clements University Hospital, Dallas, Texas, United States
🇺🇸
Parkland Health and Hospital System, Dallas, Texas, United States

Analgesics in the Pre-hospital Setting: Implications on Hemorrhage Tolerance - Morphine

Phase 1

Completed

Conditions: Healthy

Interventions: Drug: Morphine
Other: Placebo

First Posted Date: 2019-10-24

Last Posted Date: 2023-01-12

Lead Sponsor: University of Texas Southwestern Medical Center

Target Recruit Count: 44

Registration Number: NCT04138615

Locations: 🇺🇸
University of Texas Southwestern Medical Center, Dallas, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy